Research Article
Utilization Patterns of IV Iron and Erythropoiesis Stimulating Agents in Anemic Chronic Kidney Disease Patients: A Multihospital Study
Table 3
Demographic characteristics of the study sample.
| Variable | ESA + IV Iron | ESA alone | Total | | | |
| Demographic characteristics | | | |
| | n (%) | n (%) | N (%) |
| Age group (years)* | | | | 18–30 | 369 (5.53) | 4728 (6.20) | 5097 (6.14) | 31–50 | 1476 (22.10) | 19349 (25.37) | 20825 (25.11) | 51–64 | 2074 (31.06) | 24546 (32.18) | 26620 (32.09) | ≥65 | 2759 (41.31) | 27647 (36.25) | 30406 (36.66) |
| Race* | | | | White | 3348 (50.13) | 30504 (40) | 33852 (40.81) | Black | 2299 (34.43) | 32010 (41.97) | 34310 (41.36) | Hispanic | 514 (7.70) | 7742 (10.15) | 8256 (9.95) | Other | 517 (7.74) | 6013 (7.88) | 6530 (7.87) |
| Gender | | | | Male | 3615 (54.13) | 39940 (52.37) | 43555 (52.51) | Female | 3063 (45.87) | 36330 (47.63) | 39393 (47.49) |
| Primary payer* | | | | Commercial/Private payer | 1157 (17.33) | 11092 (14.54) | 12249 (14.77) | Medicare | 4588 (68.70) | 53834 (70.58) | 58422 (70.43) | Medicaid | 710 (10.63) | 9026 (11.83) | 9736 (11.74) | Self-pay | 97 (1.45) | 924 (1.21) | 1021 (1.23) | Other | 126 (1.89) | 1394 (1.83) | 1520 (1.83) |
|
|
*
Differences between the study groups were statistically significance at .
|